Andere Sprachen MeiraGTx Holdings plc

Aktien

A2JGHF

KYG596651029

MGTX

Realtime-Estimate Cboe BZX Andere Börsenplätze 21:04:16 26.04.2024			% 5 Tage	% 1. Jan.
4,715 ^USD	+0,11 %		-7,47 %	-32,91 %

16.04.	MeiraGTx Holdings plc ernennt Dr. Debra Yu zu einem Mitglied des Vergütungsausschusses und des Wissenschafts- und Technologieausschusses des Verwaltungsrats	CI
14.03.	MeiraGTx Holdings plc berichtet über die Ergebnisse für das am 31. Dezember 2023 zu Ende gegangene Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

MeiraGTx to Participate in Upcoming Investor Conferences	24.04.
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference	18.04.
MeiraGTx Holdings plc Appoints Dr. Debra Yu to Serve on Each of the Compensation Committee and Science and Technology Committee of the Board	16.04.
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates	14.03.
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
North American Morning Briefing : Inflation Data -2-	12.03.
Who are OpenAI's new board members?	11.03.
MeiraGTx to Receive $50 Million Milestone Payment from J&J's Janssen Under Bota-Vec Deal	13.02.
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13.02.
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13.02.
Progress In Preventing Blindness	26.01.
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors	03.01.
MeiraGTx sells XLRP gene therapy to Janssen	22.12.
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	21.12.
Sector Update: Health Care Stocks Advance in Afternoon Trading	21.12.
MeiraGTx Holdings Shares Rise on Sale of Remaining Bota-vec Interests to Janssen Pharmaceuticals for Up to $415 Million	21.12.
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million	21.12.
Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.	21.12.
MeiraGTx to Participate in Upcoming Investor Conferences	21.11.
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	14.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MeiraGTx Holdings plc

Aktien

A2JGHF

KYG596651029

MGTX

Andere Sprachen

Filter